Advertisement
Screener

NASDAQ:IMVT | Increase (Decrease) in Accrued Liabilities | Immunovant, Inc.

0.6 / 5 stars · 14/120 Roast Me

Immunovant, Inc. Increase (Decrease) in Accrued Liabilities

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2026-05-20

  • Immunovant, Inc. increase (decrease) in accrued liabilities for the quarter ending 2025-03-31 was $1.65M, a 89.35% decline year-over-year.
  • Immunovant, Inc. increase (decrease) in accrued liabilities for the quarter ending 2024-12-31 was $4.15M.
  • Immunovant, Inc. increase (decrease) in accrued liabilities for the quarter ending 2024-09-30 was $10.67M, a 25.11% increase year-over-year.
  • Immunovant, Inc. increase (decrease) in accrued liabilities for the quarter ending 2024-06-30 was -$7.54M.
  • Immunovant, Inc. increase (decrease) in accrued liabilities for fiscal 2026 was $45.00M, a 404.31% increase from fiscal 2025.
  • Immunovant, Inc. increase (decrease) in accrued liabilities for fiscal 2025 was $8.92M, a 561.45% increase from fiscal 2024.
  • Immunovant, Inc. increase (decrease) in accrued liabilities for fiscal 2024 was $1.35M, a 91.33% decline from fiscal 2023.
  • Immunovant, Inc. increase (decrease) in accrued liabilities for fiscal 2023 was $15.57M, a 64.36% increase from fiscal 2022.
Period endIncrease (Decrease) in Accrued Liabilities 3 monthIncrease (Decrease) in Accrued Liabilities 6 monthIncrease (Decrease) in Accrued Liabilities 6 month as first filedIncrease (Decrease) in Accrued Liabilities 9 monthIncrease (Decrease) in Accrued Liabilities 12 month
2026-03-31$45.00M
10-K · filed 2026-05-20
2025-03-31$1.65M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-20
$5.79M
derived: sum of 2 quarters · filed 2026-05-20
$16.46M
derived: sum of 3 quarters · filed 2026-05-20
$8.92M
10-K · filed 2026-05-20
2024-12-31$4.15M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-06
$14.81M
derived: sum of 2 quarters · filed 2025-02-06
$7.28M
10-Q · filed 2025-02-06
$22.73M
derived: sum of 4 quarters · filed 2026-05-20
2024-09-30$10.67M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-07
$3.13M
10-Q · filed 2024-11-07
$18.59M
derived: sum of 3 quarters · filed 2026-05-20
$13.25M
derived: sum of 4 quarters · filed 2026-05-20
2024-06-30-$7.54M
10-Q · filed 2024-08-06
$7.92M
derived: sum of 2 quarters · filed 2026-05-20
$2.58M
derived: sum of 3 quarters · filed 2026-05-20
$11.11M
derived: sum of 4 quarters · filed 2026-05-20
2024-03-31$15.46M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-20
$10.12M
derived: sum of 2 quarters · filed 2026-05-20
$18.64M
derived: sum of 3 quarters · filed 2026-05-20
$1.35M
10-K · filed 2026-05-20
2023-12-31-$5.34M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-06
$3.18M
derived: sum of 2 quarters · filed 2025-02-06
-$14.11M
10-Q · filed 2025-02-06
$180.00K
derived: sum of 4 quarters · filed 2025-05-29
2023-09-30$8.53M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-07
-$8.77M
10-Q · filed 2024-11-07
$5.52M
derived: sum of 3 quarters · filed 2025-05-29
$8.16M
derived: sum of 4 quarters · filed 2025-05-29
2023-06-30-$17.29M
10-Q · filed 2024-08-06
-$3.00M
derived: sum of 2 quarters · filed 2025-05-29
-$369.00K
derived: sum of 3 quarters · filed 2025-05-29
$3.82M
derived: sum of 4 quarters · filed 2025-05-29
2023-03-31$14.29M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-05-29
$16.93M
derived: sum of 2 quarters · filed 2025-05-29
$21.11M
derived: sum of 3 quarters · filed 2025-05-29
$15.57M
10-K · filed 2025-05-29
2022-12-31$2.63M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-02-12
$6.82M
derived: sum of 2 quarters · filed 2024-02-12
$1.28M
10-Q · filed 2024-02-12
-$5.44M
derived: sum of 4 quarters · filed 2024-02-12
2022-09-30$4.18M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-11-09
-$1.36M
10-Q · filed 2023-11-09
-$8.07M
derived: sum of 3 quarters · filed 2023-11-09
$217.00K
derived: sum of 4 quarters · filed 2023-11-09
2022-06-30-$5.54M
10-Q · filed 2023-08-10
-$12.26M
derived: sum of 2 quarters · filed 2023-08-10
-$3.97M
derived: sum of 3 quarters · filed 2023-08-10
$2.76M
derived: sum of 4 quarters · filed 2023-08-10
2022-03-31-$6.72M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-05-22
$1.57M
derived: sum of 2 quarters · filed 2023-05-22
$8.30M
derived: sum of 3 quarters · filed 2023-05-22
$9.47M
10-K · filed 2023-05-22
2021-12-31$8.29M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-02-03
$15.02M
derived: sum of 2 quarters · filed 2023-02-03
$16.19M
10-Q · filed 2023-02-03
$18.07M
derived: sum of 4 quarters · filed 2023-02-03
2021-09-30$6.73M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-11-04
$7.90M
10-Q · filed 2022-11-04
$9.78M
derived: sum of 3 quarters · filed 2022-11-04
$17.68M
derived: sum of 4 quarters · filed 2022-11-04
2021-06-30$1.17M
10-Q · filed 2022-08-05
$3.05M
derived: sum of 2 quarters · filed 2022-08-05
$10.95M
derived: sum of 3 quarters · filed 2022-08-05
$6.24M
derived: sum of 4 quarters · filed 2022-08-05
2021-03-31$1.88M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-06-08
$9.78M
derived: sum of 2 quarters · filed 2022-06-08
$5.07M
derived: sum of 3 quarters · filed 2022-06-08
$4.47M
10-K · filed 2022-06-08
2020-12-31$7.91M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-02-04
$3.19M
derived: sum of 2 quarters · filed 2022-02-04
$2.59M
10-Q · filed 2022-02-04
$5.26M
derived: sum of 4 quarters · filed 2022-02-04
2020-09-30-$4.72M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-11-05
-$5.32M
10-Q · filed 2021-11-05
-$5.17M
10-Q · filed 2020-11-12
-$2.64M
derived: sum of 3 quarters · filed 2021-11-05
$523.00K
derived: sum of 4 quarters · filed 2021-11-05
2020-06-30-$597.00K
10-Q · filed 2021-08-09
$2.08M
derived: sum of 2 quarters · filed 2021-08-09
$5.24M
derived: sum of 3 quarters · filed 2021-08-09
-$3.60M
derived: sum of 4 quarters · filed 2021-08-09
2020-03-31$2.67M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-06-01
$5.84M
derived: sum of 2 quarters · filed 2021-06-01
-$3.00M
derived: sum of 3 quarters · filed 2021-06-01
$6.50M
10-K · filed 2021-06-01
2019-12-31$3.16M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-02-16
-$5.68M
derived: sum of 2 quarters · filed 2021-02-16
$3.83M
10-Q · filed 2021-02-16
$4.80M
derived: sum of 4 quarters · filed 2021-02-16
2019-09-30-$8.84M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-11-12
$664.00K
10-Q · filed 2020-11-12
$305.67K
10-Q · filed 2019-11-13
2019-06-30$9.51M
10-Q · filed 2020-08-12
$24.15K
10-Q · filed 2019-08-12
2019-03-31$977.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-06-29
$4.91M
10-K · filed 2020-06-29
2018-12-31$3.94M
10-Q · filed 2020-02-14